Transaction #9507 · Form 4 · 0001213900-25-112301
Tenon Medical, Inc. · Purchase · Common stock
Tenon Medical, Inc. · Transacted November 14, 2025 · Filed November 18, 2025
What does this filing report?
An SEC Form 4 filing for Tenon Medical, Inc. records a purchase involving Common stock on November 14, 2025. The reported quantity was 19,455. The filing date is November 18, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Tenon Medical, Inc.
- Company CIK
- 0001560293
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 19,455
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 22,878
- Ownership description
- Not reported
- SEC acceptance time
- Nov 18, 2025, 8:42 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- FOSTER STEVEN M ↗
CEO and President · Director
CIK 0001897435
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.